scispace - formally typeset
Search or ask a question

Showing papers by "Pierre-Vladimir Ennezat published in 2016"


Journal ArticleDOI
TL;DR: Compared with hypertensive control subjects, patients with HFpEF had a depressed endothelial function in the forearm vasculature and microvasculature.

77 citations


Journal ArticleDOI
TL;DR: LV reverse remodeling assessed by ΔLVESV is a strong and reproducible predictor of outcome following CRT, and overall performance of multivariate models was better using Δ LVESV or ΔLVEF compared with ΔGLS.

22 citations


Journal ArticleDOI
TL;DR: Whether QRS narrowing should be achieved to optimize CRT placement, and thereby increase the rate of CRT responders and improve outcome, deserves further research.

20 citations


Journal ArticleDOI
TL;DR: Upgrades of speckle tracking software product upgrades may be associated with significant changes in GLS values, which could affect intersoftware and intervendor consistency and have important clinical implications for the longitudinal follow-up of patients with speckel tracking echocardiography.

19 citations


Journal ArticleDOI
01 May 2016
TL;DR: It is found that switching from one P2Y12 inhibitor to another led to a more appropriate prescription and was associated with higher scores on indicators of quality of care.
Abstract: Objective In acute coronary syndromes, switching between thienopyridines is frequent. The aims of the study were to assess the association between switching practices and quality of care. Methods Registry study performed in 213 French public university, public non-academic and private hospitals. All consecutive patients admitted for acute myocardial infarction (MI; Results Among 4101 patients receiving thienopyridines, a switch was performed in 868 (21.2%): 678 (16.5%) from clopidogrel to prasugrel and 190 (4.6%) from prasugrel to clopidogrel. Predictors of switch were ST segment elevation MI presentation, admission to a cardiology unit, previous percutaneous coronary intervention, younger age, body weight >60 kg, no history of stroke, cardiac arrest, anaemia or renal dysfunction. In patients with a switch, eligibility for prasugrel was >82% and appropriate use of a switch was 86% from clopidogrel to prasugrel and 20% from prasugrel to clopidogrel. Quality indicators scored higher in the group with a switch and also in centres where the switch rate was higher. Conclusions As applied in the French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction (FAST-MI) registry, switching from one P2Y12 inhibitor to another led to a more appropriate prescription and was associated with higher scores on indicators of quality of care.

10 citations